This inventor holds 1 USPTO granted patent. Top assignee: Daewoong Pharmaceutical Co., Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Eun Kyung Park: Innovator in Pharmaceutical Composition
Introduction
Eun Kyung Park is a notable inventor based in Yongin, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on benzoxazine derivatives. Her research focuses on developing compositions that can effectively target specific receptors in the body.
Latest Patents
Eun Kyung Park holds a patent for "Pyridyl benzoxazine derivatives, pharmaceutical composition comprising the same, and use thereof." This patent discloses a benzoxazine benzimidazole derivative, represented by Chemical Formula 1, which functions as an antagonist to the vanilloid receptor-1. The pharmaceutical composition derived from this invention can be useful for preventing or treating diseases associated with the antagonistic activity of vanilloid receptor-1, without causing hyperthermia.
Career Highlights
Eun Kyung Park is currently associated with Daewoong Pharmaceutical Co., Ltd., where she continues to advance her research in pharmaceutical innovations. Her work has garnered attention for its potential applications in treating various medical conditions.
Collaborations
Eun Kyung Park collaborates with esteemed colleagues such as Ji Duck Kim and Hong-Chul Yoon, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Eun Kyung Park's contributions to the field of pharmaceuticals exemplify her dedication to innovation and research. Her work on benzoxazine derivatives holds promise for future medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile